ADHD & Virtual Reality Research

MindReveal designs virtual reality attention tasks to study cognitive signals linked to ADHD. Learn how the protocol works, how we keep participants safe, and why this research matters.

Science-Driven Tasks

Each VR module targets executive functions such as sustained attention, working memory, and response inhibition.

Comfortable Experiences

Sessions are short (20 minutes), accessible in-browser, and designed to reduce discomfort or sensory overload.

Research Outcomes

Data contributes to ADHD research insights and helps refine future clinical hypotheses.

Ethical Safeguards

MindReveal upholds informed consent, data minimisation, and ethical review best practices.

How the VR Session Works

Participants complete short VR modules inside a browser using their own headset. Each module is structured to capture attention shifts, response timing, and executive function demands without simulating a clinical exam.

  • Sessions last under 20 minutes with frequent breaks.
  • Tasks record response accuracy, reaction times, and micro-movements.
  • Researchers review anonymised trends rather than individual diagnoses.
  • Participants can exit at any point.

FAQ: Virtual Reality & ADHD

Is VR safe for ADHD research?

Virtual reality tasks used in MindReveal research are designed to be comfortable and short. Participation is voluntary and users may stop at any time.

Can Virtual Reality diagnose ADHD?

No. Virtual reality-based tasks contribute to research and behavioural understanding but do not replace clinical diagnosis by a qualified healthcare professional.

How long does the VR ADHD session take?

Typical MindReveal VR research sessions last under 20 minutes and are designed for experimental data collection, not clinical testing.

Does MindReveal replace traditional ADHD assessments?

No. MindReveal's VR tasks are intended to complement traditional cognitive and behavioral measures, not replace them.

Stay Involved in ADHD VR Research

We are building a transparent ADHD research pipeline that complements—not replaces—clinical evaluation. Follow our mission and discover upcoming experiments that support neurodiverse communities.